drugset / Trial / NCT01063036
Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to show that the combination of entecavir and tenofovir, is effective and well tolerated in chronic hepatitis B patients who have failed previous treatment.
Timeline
- Start
- 2010-05
- Primary completion
- 2012-11
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entecavir | Small molecule | 1 mg | Oral |
| Subject | Tenofovir | Small molecule | 300 mg | Oral |